Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

Oncogene

Volumn 26, Issue 29, 2007, Pages 4234-4242

  Allende Vega, N ^a   Saville, M K ^a   Meek, D W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Mdm2; p53; TAFII250; Transcription factor; Ubiquitylation

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; PROTEIN MDM2; PROTEIN P53; RNA; RNA POLYMERASE II; TRANSCRIPTION FACTOR IID; TRANSCRIPTION FACTOR TAFII250; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACULOVIRUS; BINDING SITE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UBIQUITINATION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; HUMANS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; SPODOPTERA; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIID; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 34250831517     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210209     Document Type: Article

References (34)

1. Argentini M, Barboule N, Wasylyk B. (2001). The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene 20: 1267-1275.
2. Ashcroft M, Taya Y, Vousden KH. (2000). Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol 20: 3224-3233.
3. Blattner C, Hay TJ, Meek DW, Lane DP. (2002). Hypophosphorylation of Mdm2 augments p53 stability. Mol Cell Biol 22: 6170-6182.
4. Bottger A, Bottger V, Sparks A, Liu WL, Howard SF, Lane DP. (1997). Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol 7: 860-869.
5. Buchmann AM, Skaar JR, DeCaprio JA. (2004). Activation of a DNA damage checkpoint response in a TAF1-defective cell line. Mol Cell Biol 24: 5332-5339.
6. Dumaz N, Meek DW. (1999). p53-serine15 phosphorylation stimulates transactivation function but does not directly influence interaction with HDM2. EMBO J 18: 7002-7010.
7. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945-8951.
8. Feng J, Tamaskovic R, Yang Z, Brazil DP, Merlo A, Hess D et al. (2004). Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J Biol Chem 279: 35510-35517.
9. Ganguli G, Wasylyk B. (2003). p53-independent functions of Mdm2. Mol Cancer Res 1: 1027-1035.
10. Gronroos E, Terentiev AA, Punga T, Ericsson J. (2004). YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 101: 12165-12170.
11. Honda R, Yasuda H. (2000). Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19: 1473-1476.
12. Kawai H, Wiederschain D, Yuan Z-M. (2003). Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol Cell Biol 23: 4939-4947.
13. Kulikov R, Winter M, Blattner C. (2006). Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem 281: 28575-28583.
14. Leveillard T, Wasylyk B. (1997). The Mdm2 C-terminal region binds TAFII250 and is required for Mdm2 regulation of the cyclin A promoter. J Biol Chem 272: 30651-30661.
15. Li HH, Li AG, Sheppard HM, Liu X. (2004). Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol Cell 13: 867-878.
16. Ljungman M, Lane DP. (2004). Transcription - guarding the genome by sensing DNA damage. Nat Rev Cancer 4: 727-737.
17. Meulmeester E, Frenk R, Stad R, de Graaf P, Marine J-C, Vousden KH et al. (2003). Critical role for a central part of Mdm2 in the ubiquitylation of p53. Mol Cell Biol 23: 4929-4938.
18. Michael D, Oren M. (2003). The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13: 49-58.
19. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT et al. (2000). An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19: 2312-2323.
20. O'Brien T, Tjian R. (2000). Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes. Proc Natl Acad Sci USA 97: 2456-2461.
21. Saville MK, Sparks A, Xirodimas DP, Wardrop J, Stevenson LF, Bourdon JC et al. (2004). Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. J Biol Chem 279: 42169-42181.
22. Sekiguchi T, Miyata T, Nishimoto T. (1988). Molecular cloning of the cDNA of human X chromosomal gene (CCG1) which complements the temperature-sensitive G1 mutants, tsBN462 and ts13, of the BHK cell line. EMBO J 7: 1683-1687.
23. Shimizu H, Burch LR, Smith AJ, Dornan D, Wallace M, Ball KL et al. (2002). The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo. J Biol Chem 277: 28446-28458.
24. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P et al. (2004). Yin Yang 1 is a negative regulator of p53. Cell 117: 859-872.
25. Suzuki-Yagawa Y, Guermah M, Roeder RG. (1997). The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature. Mol Cell Biol 17: 3284-3294.
26. Vousden KH, Lu X. (2002). Live or let die: the cell's response to p53. Nature Rev Cancer 2: 594-604.
27. Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL. (2006). Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell 23: 251-263.
28. Wasserman DA, Sauer F. (2001). TAFII250: a transcriptional toolbox. J Cell Sci 114: 2895-2902.
29. Wasylyk C, Wasylyk B. (2000). Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells. Mol Cell Biol 20: 5554-5570.
30. Wu X, Bayle JH, Olson D, Levine AJ. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132.
31. Xirodimas D, Saville MK, Edling C, Lane DP, Lain S. (2001). Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20: 4972-4983.
32. Yee KS, Vousden KH. (2005). Complicating the complexity of p53. Carcinogenesis 28: 1317-1322.
33. Yu GW, Rudiger S, Veprintsev D, Freund S, Fernandez-Fernandez MR, Fersht AR. (2006). The central region of HDM2 provides a second binding site for p53. Proc Natl Acad Sci USA 103: 1227-1232.
34. Zhu Q, Yao J, Wani G, Wani MA, Wani AA. (2001). Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis. J Biol Chem 276: 29695-29701.